REPROCELL Launches AI-Designed StemEdit Gene Editing Platform
28 Jan 2026 //
PR NEWSWIRE
Reprocell USA Secures Funding from MSCRF
22 Oct 2025 //
PR NEWSWIRE
Reprocell USA secures contract from Lantern to support NSCLC therapy trial
04 May 2023 //
CLINICAL TRIALS ARENA

Market Place
Sourcing Support